当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 现金流量表

派林生物

(000403)

  

流通市值:136.87亿  总市值:138.28亿
流通股本:9.41亿   总股本:9.50亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,638,382,857.13968,008,291.47491,956,690.342,512,148,781.99
  收到的税费返还-5,367,630.65--
  收到其他与经营活动有关的现金37,527,087.5813,061,201.6412,152,522.5236,844,984.26
  经营活动现金流入小计1,675,909,944.71986,437,123.76504,109,212.862,548,993,766.25
  购买商品、接受劳务支付的现金1,078,534,154.42714,626,626.57353,664,632.061,259,197,685.51
  支付给职工以及为职工支付的现金274,556,311.9195,007,275.3123,640,586.12327,941,939.63
  支付的各项税费165,157,908.47112,024,27761,812,943.45252,748,782.7
  支付其他与经营活动有关的现金254,148,415.01157,442,842.6880,830,399.52387,314,952.14
  经营活动现金流出小计1,772,396,789.81,179,101,021.55619,948,561.152,227,203,359.98
  经营活动产生的现金流量净额-96,486,845.09-192,663,897.79-115,839,348.29321,790,406.27
二、投资活动产生的现金流量:
  收回投资收到的现金880,000,000660,000,00040,000,0001,821,060,575.34
  取得投资收益收到的现金14,126,885.6313,099,369.044,260,00034,454,090.49
  处置固定资产、无形资产和其他长期资产收回的现金净额211,783.8195,791.1854,200111,279.06
  收到的其他与投资活动有关的现金40,536,986.2926,926,027.3913,315,068.4955,035,616.42
  投资活动现金流入小计934,875,655.73700,121,187.6157,629,268.491,910,661,561.31
  购建固定资产、无形资产和其他长期资产支付的现金250,229,572.61178,057,408.0794,346,822.66520,711,316.73
  投资支付的现金1,260,050,000860,000,000510,000,0001,696,760,575.34
  支付其他与投资活动有关的现金---29,125,700
  投资活动现金流出小计1,510,279,572.611,038,057,408.07604,346,822.662,246,597,592.07
  投资活动产生的现金流量净额-575,403,916.88-337,936,220.46-546,717,554.17-335,936,030.76
三、筹资活动产生的现金流量:
  吸收投资收到的现金50,000--14,264,911.31
  其中:子公司吸收少数股东投资收到的现金50,000--40,000
  取得借款收到的现金534,318,741.72258,151,722.36120,293,204.46571,814,032.29
  筹资活动现金流入小计534,368,741.72258,151,722.36120,293,204.46586,078,943.6
  偿还债务支付的现金337,713,522.4225,020,253.08107,144,129.34408,911,726.95
  分配股利、利润或偿付利息支付的现金268,908,749.44263,568,181.664,184,355.16264,625,755.13
  支付其他与筹资活动有关的现金3,375,393.333,159,348.07845,499.256,286,176.15
  筹资活动现金流出小计609,997,665.17491,747,782.81112,173,983.75679,823,658.23
  筹资活动产生的现金流量净额-75,628,923.45-233,596,060.458,119,220.71-93,744,714.63
四、汇率变动对现金及现金等价物的影响-23,583.88-8,285.78-2,924.08-28,116.37
五、现金及现金等价物净增加额-747,543,269.3-764,204,464.48-654,440,605.83-107,918,455.49
  加:期初现金及现金等价物余额1,320,360,554.611,320,360,554.611,320,360,554.611,428,279,010.1
  期末现金及现金等价物余额572,817,285.31556,156,090.13665,919,948.781,320,360,554.61
补充资料:
  净利润-235,916,844.55-745,042,150.36
  资产减值准备-1,224,723.08-1,253,652.18
  固定资产和投资性房地产折旧-53,503,913.82-105,003,413.52
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-53,503,913.82-104,974,933.68
    投资性房地产折旧---28,479.84
  无形资产摊销-10,167,262.6-20,099,774.35
  长期待摊费用摊销-4,631,699.48-4,450,183.02
  处置固定资产、无形资产和其他长期资产的损失--785,805.25-118,875.57
  固定资产报废损失-454,300.7-3,458,747.99
  公允价值变动损失-6,227,157.72--6,380,660.77
  财务费用--18,086,692.72--40,372,453.5
  投资损失--13,721,248.52--17,738,586.13
  递延所得税--813,919.75-9,480,238.29
  其中:递延所得税资产减少-89,177.45-19,610,773.37
    递延所得税负债增加--903,097.2--10,130,535.08
  存货的减少--368,094,721.19--325,127,674.69
  经营性应收项目的减少-63,188,902.22--131,420,068.61
  经营性应付项目的增加--168,372,435.6--47,764,795.54
  现金的期末余额-556,156,090.13-1,320,360,554.61
  减:现金的期初余额-1,320,360,554.61-1,428,279,010.1
  现金及现金等价物的净增加额--764,204,464.48--107,918,455.49
公告日期2025-10-292025-08-222025-04-242025-04-24
审计意见(境内)标准无保留意见
TOP↑